Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors

NCT00572078 is an interventional clinical trial that is for Solid Tumors conditions and was started in January of 2008. This trial has 25 people enrolled who are within the adult and senior age range. This trial is funded by an industry organization, and an outside organization. The specific sponsors / contributors of this trial are as follows: Indiana University School of Medicine, Genentech, and Bayer. The following interventions were used in this trial: (drug) Sorafenib. This trial is reported / scheduled to have been completed in January of 2012.